Sale of Akzo Nobel's Organon includes Sioux City plant
By Dave Dreeszen, Journal business editor | Posted: Tuesday, March 13, 2007
The $14.4 billion sale of Akzo Nobel's Organon BioSciences division to Schering-Plough includes an Organon pharmaceutical plant in Sioux City.
The manufacturing facility at 55 1/2 Bradley St., just northeast of Sioux Gateway Airport, employs 17 people, said Keith Campbell, a Akzo Nobel spokesman. The plant's products include the anti-depression drug, Remeron, and the NuvaRing, a female conctraception device, he said.
Organon BioSciences also employs 100 people at its animal health unit facility in Worthington, Minn., just across Northwest Iowa's border.
There currently are no plans to reduce staff or change operations at any Organon location, including the Sioux City and Worthington facilities, he said.
Campbell said the current operations of Schering-Plough and Organon BioSciences, Akzo Nobel's human and animal health subsidairy, generally do not overlap.
Arnhem, Netherlands-based Akzo Nobel, whose name is derived from the Swedish company founded by dynamite inventor and Nobel Prize creator Alfred Nobel, is selling its Organon BioSciences division to return to its base as a maker of industrial chemicals and coatings. Kenilworth, N.J.-based Schering-Plough is one of the world's largest drugmakers.
The manufacturing facility at 55 1/2 Bradley St., just northeast of Sioux Gateway Airport, employs 17 people, said Keith Campbell, a Akzo Nobel spokesman. The plant's products include the anti-depression drug, Remeron, and the NuvaRing, a female conctraception device, he said.
Organon BioSciences also employs 100 people at its animal health unit facility in Worthington, Minn., just across Northwest Iowa's border.
There currently are no plans to reduce staff or change operations at any Organon location, including the Sioux City and Worthington facilities, he said.
Campbell said the current operations of Schering-Plough and Organon BioSciences, Akzo Nobel's human and animal health subsidairy, generally do not overlap.
Arnhem, Netherlands-based Akzo Nobel, whose name is derived from the Swedish company founded by dynamite inventor and Nobel Prize creator Alfred Nobel, is selling its Organon BioSciences division to return to its base as a maker of industrial chemicals and coatings. Kenilworth, N.J.-based Schering-Plough is one of the world's largest drugmakers.
Story Comments
Read More and Post Comments 0 comment(s)
Please note: The following are comments from readers. In no way do they represent the views of The Sioux City Journal or Lee Enterprises. We will not edit or alter your comments, but we do reserve the right to not post or to remove comments that violate our code of conduct. No comment may contain potentially libelous statements; obscene, explicit or racist language; personal attacks, insults or threats. Terms of Service
